Strategic Partnerships Charter Research has recently partnered with Eli Lilly to conduct significant clinical trials, demonstrating its capability to collaborate with large pharmaceutical companies and potentially expand its client base within the biotech and pharma sectors.

Innovative Technology Usage The company utilizes advanced tech tools such as React, JSON-LD, and Facebook integrations, indicating a modern approach to research services and digital engagement that can attract clients seeking high-tech research solutions.

Financial Stability With estimated revenues between $10 million and $25 million, Charter Research shows a stable financial foundation, making it a reliable partner for large-scale research projects and long-term collaborations.

Industry Focus Operating in the research services industry with a strong focus on developing new medications and therapies, the company is positioned to serve pharmaceutical and biotech firms looking to outsource clinical trials and related research activities.

Growth Potential Growing staff size within a niche market, combined with recent high-profile partnerships, indicates opportunities for business development in expanding service offerings or geographic reach to other innovative institutes and global clients.